期刊文献+

接合物蛋白Crk与CrkL在卵巢癌细胞株MCAS细胞增殖中的不同作用 被引量:1

Adaptor protein Crk differs from CrkL in promoting proliferation in ovarian cancer cell line MCAS
原文传递
导出
摘要 目的探讨接合物蛋白Crk和CrkL在卵巢癌细胞株MCAS细胞增殖中的不同作用。方法采用免疫共沉淀法检测上皮性卵巢癌细胞株MACS中Crk和CrkL蛋白与已知的与肿瘤增殖相关的上下游结合蛋白的内源性结合;用可调节性siRNA敲低MACS细胞中内源性的Crk及CrkL,观察二者对细胞生长及存活能力的影响。结果免疫共沉淀显示卵巢癌细胞株MACS中,Crk与影响细胞生长增殖的上游蛋白p130Cas及下游蛋白Sos的结合明显强于CrkL,尽管Crk与CrkL表现出部分相同的免疫原性。免疫印迹显示在加入Dox后即Crk或CrkL表达沉默被启动。Crki/CrkLi细胞中加入Dox后Crk与CrkL表达明显降低[Dox+:Crk(0.021±0.001),CrkL(0.676±0.005);Dox-:Crk(0.544±0.003),CrkL(1.282±0.007),P<0.05]。对可调节性siRNA构建之可控性Crki/CrkLi细胞的连续动态观察发现,Crki细胞表现出细胞增殖力受限仍保存生存活力,而CrkLi细胞则表现出逐渐脱壁至死亡。结论 Crk及CrkL在卵巢癌细胞MCAS的恶性增殖中扮演着不同的作用,Crk蛋白的过度表达可能直接影响着卵巢癌细胞恶性增殖,而CrkL则可能更多地参与了细胞基本生存相关的生物行为。 Objective To verify the different roles of adaptor proteins Crk and Crk-like(CrkL) in the proliferation in ovarian cancer cell line MCAS.Methods Co-immunoprecipitation was performed to detect Crk and CrkL endogenous binding proteins that were known to be associated with tumor malignant proliferation in ovarian cancer cell line MCAS.Inducible siRNA was employed to knock down endogenous Crk and CrkL expression in MCAS cells,respectively,and the growth and viability of the inducible Crk/CrkL-knockdown MCAS cells(MACS-Crki/CrkLi) were observed.Results Crk rather than CrkL strongly bound to p130Cas and Sos,which were reported to be related with cell proliferation,despite CrkL and Crk had partially the same immunogenicity.The result of Western blotting showed that Crk/CrkL started to be silenced and their expression significantly decreased when exposed to doxycycline(Dox) in MACS-Crki/CrkLi cells(Dox+: Crk 0.021±0.001,CrkL 0.676±0.005;Dox-: Crk 0.544±0.003,CrkL 1.282±0.007;P〈0.05).Serial observation of the MACS-Crki/CrkLi cells demonstrated that the Dox-induced CrkL knockdown cells presented with gradual detachment from plastic dish and even death,as compared with the Dox-induced Crk knockdown cells with reduced cell growth but remaining viability.Conclusion As compared with the role of Crk in malignant proliferation of MCAS cells,CrkL may be involved in some basic biological events associated with MCAS cell survival.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第12期1185-1188,共4页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(30672432 30772330) 重庆医科大学第一医院医学科学基金(YXJJ2009-06)~~
关键词 CRK CrkL 接合物蛋白 卵巢癌细胞株MCAS Crk CrkL adaptor protein human ovarian cancer cell line
  • 相关文献

参考文献12

  • 1Linghu H, Tsuda M, Makino Y, et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS[J]. Oncogene, 2006, 25 (25) : 3547 - 3556.
  • 2Rodrigues S P, Fathers K E, Chan G, et al. Crk1 and Crk Ⅱ function as key signaling integrators for migration and invasion of cancer cells [J]. Mol Cancer Res, 2005, 3(4): 183-194.
  • 3Feller S M. Crk family adaptors-signalling complex formation and biological roles[J]. Oncogene, 2001, 20(44): 6348-6371.
  • 4Sawyers C. Targeted cancer therapy[ J ]. Nature, 2004, 432 (7015) : 294 - 297.
  • 5Cooke S L, Brenton J D. Evolution of platinum resistance in high-grade serous ovarian cancer[ J ]. Lancet Oncol, 2011, 12(12) : 1169 - 1174.
  • 6Lage H, Denkert C. Resistance to chemotherapy in ovarian carcinoma [J]. Recent Results Cancer Res, 2007, 176:51 -60.
  • 7Watanabe T, Tsuda M, Tanaka S, et al. Adaptor prolein Crk induces Src-dependent activation of p38 MAPK in regulation of synnvial sarcoma cell proliferation[J]. Mol Cancer Res, 2009, 7(9) : 1582 - 1592.
  • 8Hernandez-Boluda J C, Cervantes F. Prognostic factors in chronic myeloid leukaemia [ J ]. Best Praet Res Clin Haematol, 2009, 22 ( 3 ) : 343 - 353.
  • 9Fathers K E, Rodrigues S, Zuo D, et al. Crk Ⅱ transgenc induces atypical mammary gland development and tumorigenesis [ J ]. Am J Pathol, 2010, 176( 1 ) : 446 -460.
  • 10Tikhmyanova N, Little J L, Golemis E A. CAS proteins in normal and pathological cell growth control [J]. Cell Mol Life Sci, 2010. 67 (7) : 1025 - 1048.

同被引文献15

  • 1倪庆锋,田原,陶金秋,等.接合物蛋白CRKL促进肝癌细胞增殖的实验研究[J/CD].中华临床医师杂志:电子版,2013,7(16):7467-7470.
  • 2Wang J, Che YL, Li G, et al. Crk and Crkl present with different expression and significance in epithelial ovarian carcinoma [ J]. Mol Carcinog,2011,50(7) :506-515.
  • 3Zhao T, Miao Z, Wang Z, et al. Overexpression of CRKL correlates with malignant cell proliferation in breast cancer[ J]. Tumour Bi- ol,2013,34(5) :2891-2897.
  • 4Wang H, Linghu H, Wang J, et al. The role of Crk/Dock180/Racl pathway in the malignant behavior of human ovarian cancer cell SKOV3 [ J]. Tumour Biol,2010,31 ( 1 ) :59-67.
  • 5Gotoh T,Hattori S,Nakamura S,et al. Identification of Rapl as a target for the Crk SH3 domain-binding guanine nucleotide-relea- sing factor C3G[ J ]. Mo! Cell Biol, 1995,15 ( 12 ) :6746-6753.
  • 6Linghu H, Tsuda M, Makino Y, et al. Involvement of adaptor pro- tein Crk in malignan feature of human ovarian cancer cell line MCAS [ J ]. Oncogene ,2006,25 ( 25 ) : 3547-3556.
  • 7Fathers KE, Rodrigues S, Zuo D, et al. Crk II transgene induces atypical mammary gland development and tumorigenesis [ J ]. Am J Pathol,2010,176 ( 1 ) :446460.
  • 8Lieberman HR, Kellogg MD, Kramer FM, et al. Lipid and other plasma markers are associated with anxiety, depression, and fa- tigue[ J]. Health Psychol,2012,31 (2) :210-216.
  • 9沈太敏,赵纯全,赵涌,令狐华.接合物蛋白Crk和CrkL在上皮性卵巢癌中的表达及意义[J].中国全科医学,2008,11(11):940-942. 被引量:5
  • 10梁英平,贾再利,陈武科,张勇.甲状腺乳头状微小癌的诊断及外科治疗[J].现代肿瘤医学,2009,17(6):1053-1055. 被引量:10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部